Sign in
4

Changes in Ownership

enGene Therapeutics Inc. Filed Acc 0000929638-24-001069

Chief Technology Officer acquired 52,940 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CHEUNG ANTHONY TZEYEW · Chief Technology Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-03-18 Exercise or conversion : show line 1 in the form +52,940 $0.89 $47,117 102,873 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-18 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −52,940 0 D
Loading xslF345X05/form4.xml…